Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502603 · ClinicalTrials.gov registry record · NA
Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT03502603: Completed NA study, sponsored by NYU Langone Health.
NCT03502603 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 137 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03502603, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
This study is aimed at investigating three new tests that will form part of a computerized tool designed to test brain/cognitive functioning. The system will be evaluated along with the tests' usability on samples of healthy controls and neurologically impaired patient participants. These new tests will be assessed with regard to reliability and validity. Reliability will be addressed through investigation of internal consistency of the test items. Validity will be evaluated relative to traditional paper-and-pencil tests and differentiation between patient and healthy participants.Each participant will complete both the computerized and paper and pencil-based tests. The results will be analyzed to see how performances on the two test types compare. The overall aim of this project is to determine if these new computerized tasks are an improvement over standard paper and pencil-based neuropsychological measures.
Interventions
- DIAGNOSTIC_TEST Railroad Test
- DIAGNOSTIC_TEST Swamp Test
- DIAGNOSTIC_TEST Presidents Recognition Test
- DIAGNOSTIC_TEST Judgment of Line Orientation
- DIAGNOSTIC_TEST Symbol Span subtest of the Wechsler Memory Scale-IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2023-12-06 |
| Phase | NA |
What the finished NCT03502603 record still lists
NCT03502603 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 5 interventions - of which Railroad Test is the first listed.
NCT03502603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03502603 about?
NCT03502603 is a clinical study titled "Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses". This study is aimed at investigating three new tests that will form part of a computerized tool designed to test brain/cognitive functioning. The system will be evaluated along with the tests' usability on samples of healthy controls and neurologically impaired patient participants. These new tests ...
What is the current status of trial NCT03502603?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2019-05-10. Estimated completion is 2023-12-06.
What interventions are being tested in trial NCT03502603?
The interventions under investigation include: Railroad Test (DIAGNOSTIC_TEST), Swamp Test (DIAGNOSTIC_TEST), Presidents Recognition Test (DIAGNOSTIC_TEST), Judgment of Line Orientation (DIAGNOSTIC_TEST), Symbol Span subtest of the Wechsler Memory Scale-IV (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03502603?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03502603's enrollment target sits among peer trials
137 722nd of 2000 higher than 1,279 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI